Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 67 68 69 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Evonik Industries AG. (7/25/12). "Press Release: Evonik Invests in Pangaea Ventures Fund III". Essen. 2012-07-25
Qiagen GmbH. (7/25/12). "Press Release: Qiagen Automated Workflow with QIAsymphony RGQ Receives AOAC Validation for Detection of Salmonella in Food Samples". Providence, RI & Hilden. 2012-07-25
Boehringer Ingelheim. (7/25/12). "Press Release: Jentadueto (linagliptin/metformin hydrochloride) Tablets Receive Approval for the Treatment of Adults with Type 2 Diabetes in Europe [for non-U.S. and non-UK Media]". Ingelheim. 2012-07-25
Lonza Group Ltd.. (7/25/12). "Press Release: Lonza Delivered Solid Business Performance in the First Half of 2012". Basel. 2012-07-25
Roche. (7/25/12). "Press Release: Roche Expands Its Blood Screening Portfolio. New Solution Improves Safety of Donated Blood". Rotkreuz & Pleasanton, CA. 2012-07-25
Sartorius AG. (7/25/12). "Press Release: Sartorius Raises Guidance Following Strong First Half. Order Intake and Sales Revenue Up by Double Digits – Earnings-Rise by One-fourth". Göttingen. 2012-07-25
Sartorius AG. (7/25/12). "Press Release: First Half of 2012. SSB Continues on the Growth Track". 2012-07-25
Sygnis Pharma AG. (7/25/12). "Press Release: Sygnis Reports Financial Results for Fiscal Year 2011/12. Strategic Realignment Successfully Initiated". Heidelberg. 2012-07-25
Biofrontera AG. (7/24/12). "Press Release: Biofrontera AG. Distribution Agreement with Spirit Healthcare Lim. for Ameluz in UK and Ireland (Ad hoc Release)". Leverkusen. 2012-07-24
Evonik Industries AG. (7/24/12). "Press Release: Evonik and BioAmber Partner on Catalysts for Sustainable Chemicals Made from Bio-based Succinic Acid". 2012-07-24
Qiagen N.V.. (7/24/12). "Press Release: Qiagen Reports Second Quarter 2012 Results, Raises Full-year Outlook and Announces Share Repurchase Program". Venlo. 2012-07-24
Antisense Pharma GmbH. (7/24/12). "Press Release: Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma. TGF-ß2 Inhibitor Has Gained Market Exclusivity in the USA for a Third Aggressive Cancer Indication". Rege 2012-07-24
Stratec Biomedical AG. (7/24/12). "Press Release: Stratec Reports Further Growth. Sales of € 55 Million in Q1–Q2/2012 (+13.3%, Q1–Q2/2011: € 48.5 Million)". Birkenfeld. 2012-07-24
SuppreMol GmbH. (7/24/12). "Press Release: SuppreMol Begins Development of Anti-IL-3 Monoclonal Antibody to Diagnose and Treat Early Stage Rheumatoid Arthritis". Munich. 2012-07-24
Boehringer Ingelheim. (7/23/12). "Press Release: Boehringer Ingelheim and Funxional Therapeutics Announce Acquisition of Funxional’s FX125L and the Somatotaxin Portfolio to Treat Inflammation". Ingelheim & Cambridge. 2012-07-23
Basilea Pharmaceutica Ltd.. (7/23/12). "Press Release: Basilea Announces Completion of Toctino (alitretinoin) Transaction with Stiefel. Basilea Receives GBP 146 Million (approximately CHF 225 Million) Upfront Payment". Basel. 2012-07-23
Illumina, Inc.. (7/23/12). "Press Release: Illumina Countersues IBS and Qiagen for Patent Infringement". San Diego, CA. 2012-07-23
Ruhr-Universität-Bochum. (7/23/12). "Pressemitteilung: Auf dem Weg zum Designerbaby? RUB-Mediziner bezieht Stellung zu Potenzial und Konsequenzen von Genanalysen – Prof. Dr. Jörg Epplen: Keine Garantie für gesunde Kinder". 2012-07-23
Bayer AG. (7/23/12). "Press Release: Phase III Trial Evaluating the Addition of Tarceva (erlotinib) to Nexavar (sorafenib) Did Not Provide Additional Benefit to Patients with Liver Cancer versus Nexavar Alone [Not intended for U.S. and UK Media]". Berlin 2012-07-23
Biofrontera AG. (7/23/12). "Press Release: Biofrontera Discusses Approval of Ameluz in the US with the FDA". Leverkusen. 2012-07-23
Ion Beam Applications S.A. (IBA). (7/23/12). "Press Release: IBA Opens Innovative International Competence Center (ICC) in Germany to Promote Safe and More Efficient Use of Radiation Therapy Dosimetry". Schwarzenbruck (Nuremberg). 2012-07-23
Auxogyn, Inc.. (7/23/12). "Press Release: Auxogyn Receives CE Mark for Non-invasive Early Embryo Viability Assessment (EEVA) Test. Company Launches Eeva Test in the European Union (EU)". Menlo Park, CA. 2012-07-23
Fresenius SE & Co. KGaA. (7/20/12). "Press Release: Fresenius Kabi Acquires Fenwal Holdings, Inc.". Bad Homburg v. d. H.. 2012-07-20
Novartis AG. (7/20/12). "Press Release: Novartis Gains FDA Approval for Afinitor in Advanced Breast Cancer Marking a Significant Milestone for Women Battling this Disease". Basel. 2012-07-20
Novartis AG. (7/19/12). "Press Release: Novartis Second Quarter Results Enhance Future Growth Prospects with Eight Significant Regulatory Milestones, on Track to Deliver 2012 Outlook". Basel. 2012-07-19
Roche. (7/19/12). "Press Release: FDA Clears Accu-Chek Combo System – Roche’s New Interactive Insulin Pump System for People with Diabetes. The System Will Be Available in the United States in the Second Half of 2012". Basel. 2012-07-19
Tecan Group Ltd.. (7/19/12). "Press Release: Powerful Walkaway qPCR Set-up from Tecan. The Roche LC480 Is Linked Directly to the Freedom EVO Workstation". Männedorf. 2012-07-19
Actelion Ltd.. (7/19/12). "Press Release: Actelion Announces Half Year 2012 Financial Results". Allschwil. 2012-07-19
Curetis AG. (7/18/12). "Press Release: Curetis AG Signs Distribution Deal in Middle East with ATC". Holzgerlingen. 2012-07-18
c-LEcta GmbH. (7/18/12). "Press Release: Aquapharm and c-LEcta to Drive Forward Discovery and Commercialisation of Marine-derived Biocatalysts". 2012-07-18
Paion AG. (7/18/12). "Press Release: Paion AG Grants License to Yichang Humanwell for Remimazolam in China. Paion Receives EUR 3 Million Upfront Payments". Aachen. 2012-07-18
Bayer AG. (7/18/12). "Press Release: Bayer HealthCare Receives Orphan Drug Designation for Its Anti-cancer Agent in the U.S. for the Treatment of Mesothelioma [Not intended for UK and US Media]". Berlin. 2012-07-18
Roche. (7/18/12). "Press Release: Roche Introduces Mobile Blood Gas Analyzer for Hospital Point-of-Care Testing in the United States. FDA Approval Grants Immediate Marketing of the cobas b 123 POC System in the U.S.". Rotkreuz. 2012-07-18
Sygnis Pharma AG. (7/18/12). "Press Release: Sygnis and Genetrix Announce Proposed Combination of Businesses of Sygnis and Genetrix’ Subsidiary X-Pol". Heidelberg. 2012-07-18
4SC AG. (7/17/12). "Press Release: 4SC Discovery, Crelux and Ribological Launch Collaboration for the Discovery and Optimisation of New Anti-cancer Drugs [no US". Planegg-Martinsried. 2012-07-17
Biobase GmbH. (7/17/12). "Press Release: Luxembourg Centre for Systems Biomedicine Appoints Biobase Genome Trax to Identify Human Genome Variations". Wolfenbüttel. 2012-07-17
ADC Therapeutics S.a.r.l.. (7/17/12). "Press Release: ADC Therapeutics Appoints Former Genmab VP Dr Patrick van Berkel as Senior VP of R&D". Lausanne. 2012-07-17
Sartorius AG. (7/17/12). "Press Release: One Does It All. Sartorius Stedim Biotech Unveils a New Generation of Its Successful Laboratory Bioreactor Series Biostat B". Göttingen. 2012-07-17
Biotest AG. (7/16/12). "Press Release: Biotest AG Starts Combination Therapy Study with BT-062 in Multiple Myeloma. Antibody-drug Conjugate BT-062 Continues to Show Good Tolerability in Monotherapy". Dreieich. 2012-07-16
Genetrix S.L.. (7/16/12). "Press Release: Genetrix Licenses »Qualiphi« Polymerase to Qiagen. Genetrix’s First Global License Agreement". Madrid. 2012-07-16
Innovationsstarter Hamburg GmbH. (7/16/12). "Pressemitteilung: Innovationsstarter Fonds Hamburg investiert in Xtal Concepts". Hamburg. 2012-07-16
High-Tech Gründerfonds Management GmbH. (7/16/12). "Press Release: Subitec GmbH Raises 4.5m Euros in Second Round Financing". Münster, Stuttgart, Bonn & Munich. 2012-07-16
Genedata AG. (7/16/12). "Press Release: Genedata Biologics Releases Advanced Support for High-throughput Protein Expression Workflows". Basel. 2012-07-16
BioKryo GmbH. (7/16/12). "Press Release: BioKryo Joins BIO Deutschland". 2012-07-16
Actelion Ltd.. (7/12/12). "Press Release: Actelion Announces Cost Saving Initiative to Be Implemented by the End of 2012. Initative Could Result in a Reduction of Up to 135 Positions". Allschwil. 2012-07-12
Bayer AG. (7/12/12). "Press Release: Kogenate Bayer Was Effective in Reducing Bleeding Frequency when Used as Secondary Prophylaxis in Adults with Severe Hemophilia A [Not intended for U.S. and UK Media]". Berlin. 2012-07-12
Labor Diagnostik GmbH Leipzig (LDL). (7/12/12). "Press Release: Qiagen and Labor Diagnostik Leipzig Join Forces to Offer Complete Veterinary Testing Portfolio". 2012-07-12
Wilex AG. (7/12/12). "Press Release: Wilex Announces Results of Successful First Half Year 2012". Munich. 2012-07-12
High-Tech Gründerfonds Management GmbH. (7/11/12). "Press Release: Epigenetics Specialist Epivios Financed by High-Tech Gründerfonds and Life Science Inkubator’s Pre-seed Fund". Bonn & Düsseldorf. 2012-07-11
Noxxon Pharma AG. (7/11/12). "Press Release: Noxxon Initiates Phase IIa of anti-CXCL12/SDF-1 Spiegelmer NOX-A12 for Treatment of Chronic Lymphocytic Leukemia". Berlin. 2012-07-11
Genedata AG. (7/11/12). "Press Release: Takeda Selects Genedata Expressionist for Genomic Profiling". Tokyo. 2012-07-11
Evotec AG. (7/10/12). "Press Release: CureBeta, a Collaboration between Evotec and Harvard University, Enters Strategic Alliance with Janssen Pharmaceuticals". Hamburg. 2012-07-10
Mologen AG. (7/10/12). "Press Release: Mologen AG Capital Increase. Proceeds of 22 Million EUR". 2012-07-10
Bayer AG. (7/10/12). "Press Release: Bayer Announces 2012 Recipients of Bayer Hemophilia Awards Program [Not intended for U.S. and UK Media]". Berlin. 2012-07-10
MPM Capital. (7/10/12). "Press Release: Dr. Mirko Scherer and Sebastian Meier-Ewert, Ph.D., Join MPM Senior Investment Team". Boston, MA & South San Francisco, CA. 2012-07-10
Metabolon, Inc.. (7/10/12). "Press Release: Metabolon Technology Now Available in Germany with Validation of Helmholtz Zentrum München Laboratory". Research Triangle Park, NC. 2012-07-10
Boehringer Ingelheim. (7/10/12). "Press Release: Boehringer Ingelheim Pursuing Health Care Innovation – New Collaboration with Healthrageous, Inc on a Digital Diabetes Self-management Program". 2012-07-10
Lonza Group Ltd.. (7/10/12). "Press Release: Lonza Launches Next Generation GS Gene Expression System. The New GS Xceed Gene Expression System Provides Up to a 6 Week Reduction in Cell Line Construction". Basel. 2012-07-10
Two Blades Foundation. (7/9/12). "Press Release: Two Blades Foundation Licenses Genome Engineering Technology to KWS". Evanston, IL. 2012-07-09
Bayer AG. (7/9/12). "Press Release: Bayer’s Xarelto (rivaroxaban) Granted Priority Review by U.S. FDA for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Long-term Prevention of Recurrent Venous Thromboembolism". Berlin. 2012-07-09
Horizon Discovery Ltd.. (7/9/12). "Press Release: Horizon Discovery and Bayer Collaborate to Develop Cell Line Models to Support Oncology Programs". Cambridge. 2012-07-09
Genkyotex S.A.. (7/9/12). "Press Release: Genkyotex Closes CHF25 Million (USD26 Million) Extension to Its Series C Financing". Geneva & Archamps. 2012-07-09
CellGenix GmbH. (7/9/12). "Press Release: CellGenix, a Leading Supplier of GMP Cytokines and Specialized Serum-free Media, Received ISO 9001:2008 Certification". Freiburg. 2012-07-09
Boehringer Ingelheim. (7/9/12). "Press Release: Boehringer Ingelheim Establishes Translational Research Collaboration with Harvard University in Areas of Unmet Medical Need". Ingelheim. 2012-07-09
Paion AG. (7/9/12). "Press Release: Preclinical Efficacy of Solulin in Radiation Injury Confirmed in US/German Research Collaboration and Published in »Nature Medicine«". Aachen. 2012-07-09
PolyQuant GmbH. (7/9/12). "Press Release: New QconCAT Kits for Absolute Protein Quantification with Mass Spectrometry". 2012-07-09
Galenica Holding AG. (7/9/12). "Press Release: PA21 – Pivotal Phase III Study Met Primary and Secondary Endpoints. Preparations for Regulatory Filings Are Underway". 2012-07-09
Reinnervate Ltd.. (7/9/12). "Press Release: Medicyte GmbH and Reinnervate Ltd to Collaborate on Development of Next Generation Predictive 3D Cell Toxicity Assays". Sedgefield. 2012-07-09
Bayer AG. (7/8/12). "Press Release: Bayer Initiates Phase III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia. BAY94-9027 Being Investigated for Prolonged Duration of Effect and Less Frequent Infusions". Berlin. 2012-07-08
Anagnostics Bioanalysis GmbH. (7/6/12). "Press Release: Anagnostics and Molzym Form Strategic Allianc Fighting Sepsis. Novel Integrated Sepsis Diagnostics". 2012-07-06
Qiagen N.V.. (7/6/12). "Press Release: Qiagen Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer. U.S. Launch therascreen KRAS RGQ PCR Kit [incl. Appendix on Personalised Medicine]". Hilden & Germa 2012-07-06
Celtic Therapeutics Management L.L.L.P.. (7/6/12). "Press Release: Cancer Research Technology and ADC Therapeutics Join Forces on Antibody Drug Conjugates". London & Lausanne. 2012-07-06
Medigene AG. (7/6/12). "Press Release: Medigene and SynCore Enter into Co-development and Commercialization Agreement for EndoTAG-1". Martinsried/Munich. 2012-07-06
Anagnostics Bioanalysis GmbH. (7/5/12). "Press Release: New Distribution Partner in Austria". 2012-07-05
Berthold Technologies GmbH & Co. KG. (7/5/12). "Press Release: Berthold Launches TriStar² Microplate Reader". Bad Wildbad. 2012-07-05
Boehringer Ingelheim. (7/5/12). "Press Release: Boehringer Ingelheim Announces Changes to Board of Management Directors. Joachim Hasenmaier to Lead New Board Division Consumer Healthcare and Animal Health". 2012-07-05
Ion Beam Applications S.A. (IBA). (7/5/12). "Press Release: Trading Update. Letter of Intent Signed for Sale of IBA Molecular Business in Canada for approx. EUR 11 Million – Good Progress on Settlement of Essen Project Litigation". Louvain-la-Neuve. 2012-07-05
Merck Serono. (7/5/12). "Press Release: Merck Serono. EXPAND Trial of Erbitux in Advanced Gastric Cancer Does Not Meet Primary Endpoint". Darmstadt. 2012-07-05
Merck Serono. (7/5/12). "Press Release: Merck Serono. Worldwide Development and Commercialization Agreement with MDxHealth for MGMT Diagnostic Test". Darmstadt. 2012-07-05
MorphoSys AG. (7/5/12). "Press Release: MorphoSys Partner OncoMed Publishes Data on HuCAL Antibody OMP-18R5. Preclinical Data Published in PNAS Demonstrates Potent Anti-cancer Activity of Antibody Targeting Wnt Pathway". 2012-07-05
Roche. (7/5/12). "Press Release: Roche Complements Hemostasis Portfolio with the Multiplate Analyzer. Personalized Anti-platelet Therapy and Stratified Bleeding Risk with Unique Diagnostic Solution". Rotkreuz. 2012-07-05
Shimadzu Corporation. (7/4/12). "Press Release: Shimadzu Presentation Digest at TIAFT". 2012-07-04
Bernhard-Nocht-Institut. (7/4/12). "Pressemitteilung: Gemeinsam gegen Infektion. Millionenförderung für die Infektionsforschung in der Metropolregion Hamburg". Hamburg, Borstel & Lübeck. 2012-07-04
Leukocare AG. (7/4/12). "Press Release: Leukocare Provides Key Technologies for Tumour Diagnosis in Personalized Medicine Research Project. Multi-national Consortium Receives €6 Million EU Grant". Munich. 2012-07-04
Addex Therapeutics S.A.. (7/3/12). "Press Release: Addex Appoints Dr. Graham Dixon as Chief Scientific Officer and Head of Research". Geneva. 2012-07-03
Bayer AG. (7/3/12). "Press Release: Bayer CropScience Acquires US-based Biological Company AgraQuest for Close to US$ 500 Million. Further Milestone to Strengthen the Fruits and Vegetables Business". Monheim. 2012-07-03
Taylor Wessing. (7/3/12). "Pressemitteilung: Taylor Wessing berät Euroimmun beim Erwerb des brasilianischen Diagnostikunternehmens GMK". 2012-07-03
Sony DADC. (7/3/12). "Press Release: Sony DADC BioSciences to Develop Smart Consumables for Next Generation of Sony Cell Sorting Instrumentation System". Salzburg. 2012-07-03
Scienion AG. (7/2/12). "Press Release: Novel Lectin-based Microarrays for Analyses of Glycosylation Structures. Procognia Microarray Production Based on Scienion’s sciFlexarrayer Technology". Dortmund & Berlin. 2012-07-02
Bayer AG. (7/2/12). "Press Release: Bayer to Present Data Hemophilia Research at the WFH 2012 World Congress. SPINART Phase III Clinical Data – BAY 94-9027 Phase I Clinical Trial Data". Berlin. 2012-07-02
Paion AG. (7/2/12). "Press Release: Paion Deutschland GmbH Receives a Grant Worth EUR 0.7 Million from the Federal Ministry of Education and Research (BMBF) for Research into the Potential of Thrombomodulin-Mutants". Aachen. 2012-07-02
KWS Saat AG. (7/2/12). "Press Release: KWS Enters Brazilian Seed Market. Acquisition of Two Breeding Companies and Entrepreneurial Participation in a Corn Seed Products and Sales Enterprise". 2012-07-02
Medicyte GmbH. (7/2/12). "Press Release: Medicyte Coordinates EU-funded Collaboration on Biomimetic Bioartificial Liver. Research Is Receiving 4.2 Mio Euros from the European Union Seventh Framework Programme". Heidelberg. 2012-07-02
Medigene AG. (7/2/12). "Press Release: Medigene’s Veregen Receives Marketing Authorization in France. Market Launch in France Expected in 2013". Martinsried/Munich. 2012-07-02
Portigon AG. (7/2/12). "Press Release: Shareholder Structure and Supervisory Board of Portigon AG". 2012-07-02
4SC AG. (6/29/12). "Press Release: 4SC AG Capital Increase. Subscription Offer Period Ended, Rump Placement Started [not for USA, Australia, Canada, Japan et al.]". Planegg-Martinsried. 2012-06-29
4SC AG. (6/29/12). "Press Release: 4SC AG. Volume of the Capital Increase Has Been Determined at 8,403,510 New Shares, Gross Proceeds of EUR 12,605,265.00 Expected [not for USA, Australia, Canada, Japan et al.]". Planegg-Martinsried. 2012-06-29
Fresenius SE & Co. KGaA. (6/29/12). "Press Release: Offer to Acquire All Outstanding Rhön-Klinikum AG Shares. Minimum Acceptance Threshold of More than 90% Not Reached". Bad Homburg v. d. H.. 2012-06-29
Bayer AG. (6/28/12). "Press Release: U.S. FDA Grants Priority Review to the New Drug Application for Bayer’s Regorafenib to Treat Patients with Metastatic Colorectal Cancer". Berlin. 2012-06-28
Dynamic Biosensors GmbH. (6/28/12). "Press Release: DBS Signs License Agreement with BayPat and Fujitsu". 2012-06-28
next pagenext page 1 2 3 ... 67 68 69 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top